We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Micromotion and stress shielding between taper fluted and cylindrical femoral stems for Paprosky bone deficiency type IIIB

    Purpose

    Taper fluted and cylindrical femoral stems have been commonly used for revision surgery with femoral bone loss. Shape and material differences...

    S. Limmahakhun, N. Adulkasem, ... S. Rojanasthien in MUSCULOSKELETAL SURGERY
    Article 21 March 2023
  2. Laparoscopic Resection of Perihilar Cholangiocarcinoma Type IIIb: A Video Demonstration of No-Touch En-Block Technique and Radical Lymphadenectomy

    Background

    Minimally invasive surgery for perihilar cholangiocarcinoma (pCCA) is in an exploratory phase by now and is only recommended for carefully...

    Ningyuan Wen, Wei Gao, ... Fuyu Li in Annals of Surgical Oncology
    Article 16 May 2023
  3. Monolateral external fixation versus internal fixation of Gustilo IIIB open tibial fractures: a multicenter comparative study

    Purpose

    Gustilo IIIB open tibial fractures are associated with significant risks of complications particularly nonunion and fracture-related...

    Olaoluwa Moses Shodipo, Mosimabale Joe Balogun, ... Omolade Ayoola Lasebikan in European Journal of Trauma and Emergency Surgery
    Article 05 July 2023
  4. Comparison of Bismuth IIIa and IIIb Types of Hilar Cholangiocarcinoma: a Multi-center Case Series Analysis of China

    The differences between Bismuth IIIa and IIIb types of hilar cholangiocarcinoma are unclear. Thus, this study aimed to compare the clinical...

    Zun-Qiang Zhou, Jiao Guan, ... Zheng-Yun Zhang in Indian Journal of Surgery
    Article 08 November 2022
  5. Type IIIb endoleak due to stent suture line fabric breakage in the Endurant stent graft: a case report

    Background

    Early type IIIb endoleak is a very rare complication of endovascular aneurysm repair (EVAR).

    Case presentation

    An 87-year-old man was...

    Satoshi Takahashi, Toshiya Nishibe, ... Hitoshi Ogino in Surgical Case Reports
    Article Open access 19 April 2022
  6. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer

    Background and objectives

    We explored the prognostic usefulness of the pan-immune-inflammation value (PIV) in patients with stage IIIB/C...

    Erkan Topkan, Ahmet Kucuk, ... Ugur Selek in Discover Oncology
    Article Open access 13 December 2023
  7. Intraoperative implantation of 125I seeds improves prognosis in refractory stage IIIB cervical cancer: a case report and literature review

    Background

    Concurrent chemoradiation is the standard treatment for advanced cervical cancer. However some patients still have a poor prognosis, and...

    Jialin Wu, Junying Tang, ... Lin **ao in BMC Women's Health
    Article Open access 02 March 2024
  8. Real-world clinical outcome and safety of adjuvant human Interferon-alpha1b in resected stage IIIB or IIIC melanoma: results of a retrospective study

    Background

    Human interferon-α1b (hIFN-α1b) is the first genetically engineered drug approved by the National Medical Product Administration for cancer...

    Meiyan Gao, Yuehua Li, ... Qiong Shi in Holistic Integrative Oncology
    Article Open access 20 May 2024
  9. Surgery for stage IIB–IIIB small cell lung cancer

    Purpose

    The NCCN guidelines do not recommend surgery for T3–4N0M0/T1–4N1–2M0 small cell lung cancer (SCLC) due to a lack of evidence.

    Methods ...
    Zhida Huang, Yue Liu, ... Peng Zhang in World Journal of Surgical Oncology
    Article Open access 23 October 2023
  10. Cyclic thrombocytopenia related to erythropoietin-dependent anti-platelet anti-GPIV/IIIb antibody in hemodialysis

    We describe herein the case of a 65-year-old patient on chronic hemodialysis with a medical history of idiopathic thrombocytopenia who experienced...

    Nans Florens, Jean-Claude Bordet, ... Fitsum Guebre-Egziabher in Journal of Nephrology
    Article 21 May 2022
  11. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study

    Introduction

    Many immunization programs in Europe recommend quadrivalent meningococcal vaccinations, which are often administered concomitantly with...

    Javier Díez-Domingo, Róbert Simkó, ... Isabelle Bertrand-Gerentes in Infectious Diseases and Therapy
    Article Open access 02 July 2024
  12. Efficacy and safety of **an-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial

    Introduction

    Colon cancer remains one of the most prevalent cancers worldwide. Unfortunately, there are no recognized and effective therapeutic...

    Xuechen Geng, Ziqiang Wang, ... Haibo Cheng in BMC Complementary Medicine and Therapies
    Article Open access 17 July 2023
  13. Robotic Resection of a Type IIIB Klatskin Tumor

    Perihilar cholangiocarcinoma (Klatskin tumor) is one of the most challenging hepatobiliary cancers to treat due to its critical location and tendency...

    Iswanto Sucandy, Sharona Ross, Alexander Rosemurgy in Journal of Gastrointestinal Surgery
    Article 16 March 2021
  14. Limb salvage versus primary amputation in Gustilo–Anderson IIIB and IIIC tibial fractures: a systematic review and meta-analysis

    Introduction

    The last systematic review on this topic was published in 2008. With advances in surgical techniques, patients with mangled extremities...

    Hannah Jia Hui Ng, Ernest ** Guang Ang, ... Vaikunthan Rajaratnam in Archives of Orthopaedic and Trauma Surgery
    Article 13 February 2023
  15. Effects of traditional Chinese medicine collaborative model (TCMCM) combined with adjuvant chemotherapy on IIIb and IIIc gastric cancer: a protocol for a randomized controlled trial

    Background

    Metastasis and/or recurrence can decrease the survival time of gastric cancer patients undergoing radical operation. Among them, those with...

    Zhaoyan Li, Guangtao Zhang, ... Aiguang Zhao in Trials
    Article Open access 21 January 2022
  16. Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan

    Background

    Real-world clinical experience with afatinib as a treatment for advanced lung adenocarcinoma harboring uncommon epidermal growth factor...

    **-Chih Hsu, Suey-Haur Lee, ... Chin-Chou Wang in Targeted Oncology
    Article Open access 20 February 2023
  17. The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study

    Background

    AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive,...

    Paul Emery, Yoshiya Tanaka, ... Roy Fleischmann in Arthritis Research & Therapy
    Article Open access 22 April 2023
  18. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

    Background

    FGFR2 genomic alterations are observed in 10–20% of cholangiocarcinoma (CCA). Although FGFR2 fusions are an important actionable target, FGFR2...

    Pedro Luiz Serrano Uson Junior, Thomas T. DeLeon, ... Mitesh J. Borad in Digestive Diseases and Sciences
    Article 13 November 2021
  19. Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial

    Introduction

    While some clinical studies have shown that PD-1 and PD-L1 can also be an effective neoadjuvant treatment for early-stage non-small cell...

    Chao Sun, Yunpeng Liu, ... Kewei Ma in Journal of Cancer Research and Clinical Oncology
    Article 22 February 2022
  20. A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China

    Background

    Afatinib has been shown as a suitable option for the treatment of epidermal growth factor receptor mutation-positive ( EGFR m+)...

    Hai-Yan Tu, Jifeng Feng, ... Yi-Long Wu in Targeted Oncology
    Article Open access 12 January 2022
Did you find what you were looking for? Share feedback.